CLINICAL TRIALS PROFILE FOR ETONOGESTREL

All Clinical Trials for Etonogestrel

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00369967 ↗	Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents	Terminated	American College of Obstetricians and Gynecologists	N/A	2007-02-01	We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
NCT00369967 ↗	Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents	Terminated	Bayer	N/A	2007-02-01	We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
NCT00369967 ↗	Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents	Terminated	Virginia Commonwealth University	N/A	2007-02-01	We hypothesize that using "quick start" initiation of the contraceptive vaginal ring in adolescents seeking birth control will improve compliance compared to traditional start. We will conduct a randomized controlled trial comparing "quick start" to traditional start initiation of the contraceptive vaginal ring in adolescents seeking birth control. The primary study outcome is method continuation at 3, 6, and 12 months. Secondary outcomes include abnormal bleeding, product satisfaction, and adverse events.
NCT00403793 ↗	Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)	Completed	Bayer	Phase 2	2003-10-01	Male volunteers receive a new hormonal contraceptive consisting of an implant releasing a hormone and hormone injections in order to investigate the suppressive effect on sperm production and reversibility of sperm production after end of treatment.

Clinical Trial Conditions for Etonogestrel

Condition Name

Condition Name for Etonogestrel
Intervention	Trials
Contraception	34
HIV	5
Bleeding	3
Breakthrough Bleeding	3

Condition MeSH

Condition MeSH for Etonogestrel
Intervention	Trials
Hemorrhage	11
Uterine Hemorrhage	8
Dysmenorrhea	4
Metrorrhagia	3

Clinical Trial Locations for Etonogestrel

Trials by Country

Trials by Country for Etonogestrel
Location	Trials
United States	78
Brazil	8
Peru	3
South Africa	3
Thailand	3

Trials by US State

Trials by US State for Etonogestrel
Location	Trials
Colorado	9
Oregon	6
Virginia	5
North Carolina	4
Utah	4

Clinical Trial Progress for Etonogestrel

Clinical Trial Phase

Clinical Trial Phase for Etonogestrel
Clinical Trial Phase	Trials
Phase 4	30
Phase 3	9
Phase 2/Phase 3	2

Clinical Trial Status

Clinical Trial Status for Etonogestrel
Clinical Trial Phase	Trials
Completed	33
Not yet recruiting	11
Recruiting	10

Clinical Trial Sponsors for Etonogestrel

Sponsor Name

Sponsor Name for Etonogestrel
Sponsor	Trials
Merck Sharp & Dohme Corp.	20
University of Colorado, Denver	7
University of Pittsburgh	6

Sponsor Type

Sponsor Type for Etonogestrel
Sponsor	Trials
Other	85
Industry	27
NIH	6